A Multi-centre, Prospective Surveillance to Assess Mid-term Performance of the Mpact Cup

Status:	Recruiting
Conditions:	Arthritis, Osteoarthritis (OA), Orthopedic, Orthopedic
Therapuetic Areas:	Rheumatology, Orthopedics / Podiatry
Healthy:	No
Age Range:	Any
Updated:	4/17/2018
Start Date:	March 2013
End Date:	March 2024
Contact:	Mara Colombo
Email:	colombo@medacta.ch
Phone:	0041 91 6966060

A Multi-centre, Prospective Post Marketing Surveillance Study to Assess Mid-term Performance of the Mpact Cup in Subjects Requiring Primary Total Hip Arthroplasty

This is a multi-centre, prospective post marketing surveillance study to assess mid-term
performance of the Mpact cup in subjects requiring primary total hip arthroplasty.

Inclusion Criteria:

- Patients who are willing and able to provide written informed consent for
participation in the study. Written informed consent must be obtained prior to the
patient's surgery.

- Those presenting with disease that meets the indications for use for Medacta USA
implants defined by this study (on-label use).

- Patients must be willing to comply with the pre and post-operative evaluation
schedule.

Exclusion Criteria:

- Those with one or more medical conditions identified as a contraindication defined by
the labeling on any Medacta implants used in this study.

We found this trial at

sites

Vail Orthopedics, P.C.

Denver, Colorado 80230

Principal Investigator: Derek Johnson, MD

Phone: 303-214-4500

from

Denver, CO